Filing Flows › Cardlytics (CDLX) › Q3 2026 › vs Q2 2026
Cardlytics (CDLX) Q3 2026 vs Q2 2026 (quarter over quarter)
Cardlytics's revenue fell $4.0M (-11%) from $36.9M in Q2 2026 to $32.9M in Q3 2026. The biggest changes: Engagement based pricing −$2.2M (-9%); Served based pricing −$1.7M (-15%); Other Revenue(1) −$66K (-6%).
Cardlytics, Q3 2026: revenue $32.9M (-30% year over year), operating margin -16.5%, net loss $8.9M, operating cash flow −$5.9M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Engagement based pricing | $21.7M | $23.9M | −$2.2M | -9% |
| Served based pricing | $10.1M | $11.8M | −$1.7M | -15% |
| Other Revenue(1) | $1.1M | $1.2M | −$66K | -6% |
| Revenue | $32.9M | $36.9M | −$4.0M | -11% |
| Net loss | $8.9M | $14.9M | −$5.9M | -40% |
| Costs & expenses | $41.8M | $51.8M | −$9.9M | -19% |
| Operating costs | $38.3M | $42.3M | −$4.0M | -9% |
| Interest & other, net | $3.5M | $9.4M | −$5.9M | -63% |
| Research & development | $3.7M | $5.5M | −$1.8M | -33% |
| Sales & marketing | $6.7M | $6.6M | $74K | +1% |
| General & admin | $7.1M | $7.9M | −$766K | -10% |
| Other operating costs | $20.8M | $22.3M | −$1.5M | -7% |
| Operating cash sources | $11.7M | $15.0M | −$3.3M | -22% |
| Depreciation & amortization | $4.2M | $4.1M | $121K | +3% |
| Share-based compensation | $1.6M | $2.4M | −$730K | -31% |
| Cash used in operations | $5.9M | $8.6M | −$2.7M | -31% |
| Net loss absorbed | $8.9M | $14.9M | −$5.9M | -40% |
| Working capital & other | $2.8M | $137K | $2.6M | 20× |
Questions
How much did Cardlytics's revenue grow quarter over quarter in Q3 2026?
Cardlytics's revenue fell $4.0M (-11%) from $36.9M in Q2 2026 to $32.9M in Q3 2026.
What drove Cardlytics's revenue change in Q3 2026?
Engagement based pricing −$2.2M (-9%); Served based pricing −$1.7M (-15%); Other Revenue(1) −$66K (-6%).